ResMed (ASX:RMD): Investors who bought the dip would be satisfied, but is there any growth left in this one?
ResMed (ASX:RMD) is one of the few ASX healthcare stocks that has successfully made it in the USA. In this…
Read MoreZip shares have doubled in 12 months, but is this a legitimate turnaround or a dead cat bounce?
Ever since Afterpay was taken over in 2021, Zip shares have remained the best way to play the Buy Now,…
Read MoreHow do analysts value stocks? Here are 3 key ways to judge what a stock is worth
In this article we answer the question ‘How do analysts value stocks?‘ By knowing how they do it, you can…
Read More